I'd hate to be short Pall (NYSE:PLL), as large companies in the filtration space often seem as close to bulletproof as you can find in the market. So even though sell-side analysts chronically overestimate Pall's free cash flow, investors remain happy with a company that admittedly enjoys strong share and a very lucrative channel of repeat business. While I think Pall's shares remain overvalued, I don't have any particular reason to believe that the shares will sell off dramatically, as the life sciences business should be stable and the industrial business should start improving next year.
On Target In Fiscal Q4
There are always plenty of moving parts within Pall's results, as the company sells into so many different end markets, but the end result performance was pretty much on target.
Revenue fell almost 1% as reported to close the fiscal year, but revenue in local currency terms rose half a point. Life sciences was up 6% for the quarter, as strength in biopharma offset weaker conditions in the Chinese and European food and beverage sector. Customer utilization levels in industrial markets remain a real issue, though, and the company saw a 5% decline (local currency) in industrial sales, with particular weakness in microelectronics and municipal water.
Improving the company's cost structure has been a key topic at Pall, though this quarter didn't really show the progress that the company has been making. Gross margin was flat, as a slight improvement in industrial was offset by a nearly one point decline in life sciences. Operating income declined 3% at the corporate level, while life sciences segment earnings were flat and industrial improved 1%.
Not Many Surprises, All Things Considered
This really looked like an “as expected” quarter all across the board. Pall's life science performance was consistent with an earlier report from Sartorius, while Donaldson (NYSE:DCI) reported weakness in the industrial sector and Entegris (Nasdaq:ENTG) gave weak guidance on the basis of soft trends in semiconductors and microelectronics.
There really isn't that much joy (or momentum) in industrial filtration/fluid handling right now. Leading fluid handling company IDEX (NYSE:IEX) saw just 2% organic sales growth in the calendar second quarter, though orders were better. Likewise, Xylem (NYSE:XYL), a “water technology” company, saw sales decline in the quarter, though Flowserve (NYSE:FLS) saw mid single-digit revneue growth. With industrial activity lower almost across the board, utilization rates have been quite poor (50% or below in some cases), and that has reduced the need for replacement consumables. As industrial activity picks up, so should Pall's industrial business, but management's guidance doesn't suggest a big recovery next year.
Strong Share And Ample Liquidity, Plus Cost-Cutting
I understand why Pall is popular. A very large percentage of the company's revenue comes from very profitable replacement/consumable components, and once the company makes a system sale, the relationship tends to be long and lucrative. Moreover, while Pall's products are quite profitable to them, they're typically not expensive enough to the end customers to justify replacing entire systems and interrupting operations.
It's also certainly true that the company's balance sheet is in good shape, which gives the company a lot of options in terms of returning capital to shareholders or growing the business through acquisitions. Last and not least, a relatively new management team still has room to maneuver with operational improvements that can boost margins.
The Bottom Line
The only thing I don't like about Pall is the price – this company rarely ever gets very cheap and investors are willing to pay a lot for its consistent cash flows. With that, even the fact that Wall Street sell-side analysis often over-estimate free cash flows doesn't really impact the stock. Not surprisingly, I don't think these shares are much of a bargain today, but I'd be in no rush to sell just on that basis.
Disclosure – At the time of writing, the author did not own shares of any company mentioned in this article.

Related Articles
  1. Stock Analysis

    Starbucks: Profiting One Cup at a Time (SBUX)

    Starbucks is everywhere. But is it a worthwhile business? Ask the shareholders who've made it one of the world's most successful companies.
  2. Stock Analysis

    How Medtronic Makes Money (MDT)

    Here's the story of an American medical device firm that covers almost every segment in medicine and recently moved to Ireland to pay less in taxes.
  3. Investing News

    Latest Labor Numbers: Good News for the Market?

    Some economic numbers are indicating that the labor market is outperforming the stock market. Should investors be bullish?
  4. Investing News

    Stocks with Big Dividend Yields: 'It's a Trap!'

    Should you seek high yielding-dividend stocks in the current investment environment?
  5. Investing News

    Should You Be Betting with Buffett Right Now?

    Following Warren Buffett's stock picks has historically been a good strategy. Is considering his biggest holdings in 2016 a good idea?
  6. Products and Investments

    Cash vs. Stocks: How to Decide Which is Best

    Is it better to keep your money in cash or is a down market a good time to buy stocks at a lower cost?
  7. Investing News

    Who Does Cheap Oil Benefit? See This Stock (DG)

    Cheap oil won't benefit most companies, but this retailer might buck that trend.
  8. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  9. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  10. Investing News

    Today's Sell-off: Are We in a Margin Liquidation?

    If we're in market liquidation, is it good news or bad news? That party depends on your timeframe.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
Trading Center